{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T06:48:13Z","timestamp":1773557293060,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bmc.2024.117682","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T17:22:10Z","timestamp":1710264130000},"page":"117682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Design, synthesis, and antiviral activity of 1-aryl-4-arylmethylpiperazine derivatives as Zika virus inhibitors with broad antiviral spectrum"],"prefix":"10.1016","volume":"103","author":[{"given":"Yingjie","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117682_b0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus. I. Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.bmc.2024.117682_b0010","doi-asserted-by":"crossref","unstructured":"Duffy, M. R.; Chen, T. H.; Hancock, W. T.; Powers, A. M.; Kool, J. L.; Lanciotti, R. S.; Pretrick, M.; Marfel, M.; Holzbauer, S.; Dubray, C.; Guillaumot, L.; Griggs, A.; Bel, M.; Lambert, A. J.; Laven, J.; Kosoy, O.; Panella, A.; Biggerstaff, B. J.; Fischer, M.; Hayes, E. B., Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009, 360 (24), 2536-43.","DOI":"10.1056\/NEJMoa0805715"},{"key":"10.1016\/j.bmc.2024.117682_b0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2017.03.001","article-title":"Zika virus: History, epidemiology, transmission, and clinical presentation","volume":"308","author":"Song","year":"2017","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.bmc.2024.117682_b0020","doi-asserted-by":"crossref","unstructured":"Schuler-Faccini, L.; Ribeiro, E. M.; Feitosa, I. M.; Horovitz, D. D.; Cavalcanti, D. P.; Pessoa, A.; Doriqui, M. J.; Neri, J. I.; Neto, J. M.; Wanderley, H. Y.; Cernach, M.; El-Husny, A. S.; Pone, M. V.; Serao, C. L.; Sanseverino, M. T.; Brazilian Medical Genetics Society-Zika Embryopathy Task, F., Possible Association Between Zika Virus Infection and Microcephaly - Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016, 65 (3), 59-62.","DOI":"10.15585\/mmwr.mm6503e2"},{"key":"10.1016\/j.bmc.2024.117682_b0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/CMR.00072-15","article-title":"Zika virus","volume":"29","author":"Musso","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmc.2024.117682_b0030","doi-asserted-by":"crossref","unstructured":"Hazin, A. N.; Poretti, A.; Di Cavalcanti Souza Cruz, D.; Tenorio, M.; van der Linden, A.; Pena, L. J.; Brito, C.; Gil, L. H.; de Barros Miranda-Filho, D.; Marques, E. T.; Turchi Martelli, C. M.; Alves, J. G.; Huisman, T. A.; Microcephaly Epidemic Research, G., Computed Tomographic Findings in Microcephaly Associated with Zika Virus. N Engl J Med 2016, 374 (22), 2193-5.","DOI":"10.1056\/NEJMc1603617"},{"key":"10.1016\/j.bmc.2024.117682_b0035","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/s41591-019-0496-1","article-title":"Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children","volume":"25","author":"Nielsen-Saines","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.bmc.2024.117682_b0040","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2024.117682_b0045","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMc1602964","article-title":"Zika virus associated with meningoencephalitis","volume":"374","author":"Carteaux","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2024.117682_b0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1473-3099(18)30718-7","article-title":"Long-term circulation of Zika virus in Thailand: an observational study","volume":"19","author":"Ruchusatsawat","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmc.2024.117682_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsle\/fnx244","article-title":"Vector-borne diseases and climate change: A European perspective","volume":"365","author":"Semenza","year":"2018","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.bmc.2024.117682_b0060","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1021\/acs.jmedchem.0c00232","article-title":"2-((4-Arylpiperazin-1-yl)methyl)benzonitrile derivatives as orally available inhibitors of hepatitis C virus with a novel mechanism of action","volume":"63","author":"Jiang","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117682_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106265","article-title":"Identification of an N-phenylsulfonyl-2-(piperazin-1-yl)methyl-benzonitrile derivative as Zika virus entry inhibitor","volume":"130","author":"Quan","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117682_b0070","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2024.117682_b0075","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cell.2016.05.008","article-title":"Zika virus infection during pregnancy in mice causes placental damage and fetal demise","volume":"165","author":"Miner","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2024.117682_b0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.chom.2016.07.002","article-title":"Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission","volume":"20","author":"Tabata","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bmc.2024.117682_b0085","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1039\/b610069b","article-title":"Fragment screening: an introduction","volume":"2","author":"Leach","year":"2006","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.bmc.2024.117682_b0090","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/ml500146d","article-title":"Validity of ligand efficiency metrics","volume":"5","author":"Murray","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117682_b0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/ml4004638","article-title":"Improving the plausibility of success with inefficient metrics","volume":"5","author":"Shultz","year":"2014","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117682_b0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2024.117682_b0105","doi-asserted-by":"crossref","first-page":"ofw175","DOI":"10.1093\/ofid\/ofw175","article-title":"Adenosine analog NITD008 is a potent inhibitor of Zika virus","volume":"3","author":"Deng","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bmc.2024.117682_b0110","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2024.117682_b0115","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1073\/pnas.1620558114","article-title":"AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses","volume":"114","author":"Richard","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2024.117682_b0120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.apsb.2014.06.005","article-title":"A cell-based high-throughput approach to identify inhibitors of influenza A virus","volume":"4","author":"Gao","year":"2014","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2024.117682_b0125","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1128\/AAC.00814-16","article-title":"Safe and sensitive antiviral screening platform based on recombinant human coronavirus OC43 expressing the luciferase reporter gene","volume":"60","author":"Shen","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2024.117682_b0130","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1586\/eri.12.104","article-title":"Development of novel entry inhibitors targeting emerging viruses","volume":"10","author":"Zhou","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.bmc.2024.117682_b0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624000968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624000968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:19:38Z","timestamp":1714781978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624000968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":27,"alternative-id":["S0968089624000968"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117682","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and antiviral activity of 1-aryl-4-arylmethylpiperazine derivatives as Zika virus inhibitors with broad antiviral spectrum","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117682"}}